Rosmarinic acid attenuates hepatic ischemia and reperfusion injury in rats

•Rosmarinic acid (RosmA) protects hepatocytes against ischemia/reperfusion (I/R) injury.•RosmA attenuates tissue oxidative/nitrosative stress following liver I/R.•RosmA reduces hepatic eNOS and iNOS expressions and NO levels following liver I/R.•RosmA inhibits the nuclear factor-κB signaling pathway...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Food and chemical toxicology 2014-12, Vol.74, p.270-278
Hauptverfasser: Ramalho, Leandra Naira Z., Pasta, Ângelo Augusto C., Terra, Vânia Aparecida, Augusto, Marlei Josiele, Sanches, Sheila Cristina, Souza-Neto, Fernando P., Cecchini, Rubens, Gulin, Francine, Ramalho, Fernando Silva
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Rosmarinic acid (RosmA) protects hepatocytes against ischemia/reperfusion (I/R) injury.•RosmA attenuates tissue oxidative/nitrosative stress following liver I/R.•RosmA reduces hepatic eNOS and iNOS expressions and NO levels following liver I/R.•RosmA inhibits the nuclear factor-κB signaling pathway in the setting of liver I/R.•RosmA exerts potent anti-inflammatory and antioxidant effects in the ischemic liver. Rosmarinic acid (RosmA) demonstrates antioxidant and anti-inflammatory properties. We investigated the effect of RosmA on liver ischemia/reperfusion injury. Rats were submitted to 60 min of ischemia plus saline or RosmA treatment (150 mg/kg BW intraperitoneally) followed by 6 h of reperfusion. Hepatocellular injury was evaluated according to aminotransferase activity and histological damage. Hepatic neutrophil accumulation was also evaluated. Oxidative/nitrosative stress was estimated by measuring the reduced glutathione, lipid hydroperoxide and nitrotyrosine levels. Endothelial and inducible nitric oxide synthase (eNOS/iNOS) and nitric oxide (NO) were assessed with immunoblotting and chemiluminescence assays. Hepatic tumor necrosis factor-alpha (TNF-α) and interleukin-1beta mRNA were assessed using real-time PCR, and nuclear factor-kappaB (NF-κB) activation was estimated by immunostaining. RosmA treatment reduced hepatocellular damage, neutrophil infiltration and all oxidative/nitrosative stress parameters. RosmA decreased the liver content of eNOS/iNOS and NO, attenuated NF-κB activation, and down-regulated TNF-α and interleukin-1beta gene expression. These data indicate that RosmA exerts anti-inflammatory and antioxidant effects in the ischemic liver, thereby protecting hepatocytes against ischemia/reperfusion injury. The mechanisms underlying these effects may be related to the inhibitory potential of RosmA on the NF-κB signaling pathway and the reduction of iNOS and eNOS expressions and NO levels, in addition to its natural antioxidant capability.
ISSN:0278-6915
1873-6351
DOI:10.1016/j.fct.2014.10.004